Ascendia’s programs are focused on providing our clients with rapid early-stage development services. Depending on the needs of the specific program, our services can begin with a pre-formulation assessment, including solution-based trial formulations for in-vitro testing. If a molecule is more advanced, Ascendia can provide formulation optimization services designed to provide a commercial dosage presentation. Finally, our programs can conclude with manufacture of cGMP clinical trial materials for a first-in-man study. The goal of every program is to advance it as quickly as possible to key decision points.
OUR SERVICE AREAS
SPECIAL DEVELOPMENT PROGRAMS
As a specialty CDMO, Ascendia offers expertise in a wide variety of development programs. We have acquired the capability to work on early-stage formulations of programs as diverse as peptides, high-potency molecules, nano-particles, animal health products, and parenteral dosage forms. Ascendia prides itself on working on the unique and challenging programs that contribute to the unique selling proposition of our client’s ideas.